Synthesis and biological evaluation of new LTA4 analogs

[1]  R. Labaudinière,et al.  Omega-[(omega-arylalkyl)aryl]alkanoic acids: a new class of specific LTA4 hydrolase inhibitors. , 1992, Journal of medicinal chemistry.

[2]  R. Labaudinière,et al.  Omega-[(omega-arylalkyl)thienyl]alkanoic acids: from specific LTA4 hydrolase inhibitors to LTB4 receptor antagonists. , 1992, Journal of medicinal chemistry.

[3]  R. Grée,et al.  Fumaraldehyde monodimethyl acetal: An easily accessible and versatile intermediate. , 1987 .

[4]  S. Charleson,et al.  Neutrophil LTA4 hydrolases and leukotriene B4 receptors: effects of leukotriene epoxides and their enzymatic products. , 1986, Prostaglandins, leukotrienes, and medicine.

[5]  R. Bryant,et al.  Lipoxygenase products of arachidonic acid modulate biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human neutrophils via phospholipase A2. , 1985, The Journal of biological chemistry.

[6]  J. Patterson,et al.  Synthesis of (8E,10E,12Z,15Z)-6-oxaheneicosa-8,10,12,15-tetraenoic acid, seco-leukotriene A4 , 1983 .

[7]  M. Holroyde,et al.  Kinetics of action of two leukotriene antagonists on guinea pig ileum. , 1983, European journal of pharmacology.

[8]  R. Zamboni,et al.  Synthesis of the aza analog of LTA4 , 1983 .

[9]  E. Corey,et al.  A stereospecific synthesis of a dihydrofuran analog of leukotriene A4 , 1990 .

[10]  M. Toda,et al.  Synthesis and 5-lipoxygenase inhibitory activities of eicosanoid compounds. , 1983, Journal of medicinal chemistry.